1 Min Read
May 16 (Reuters) - Albireo Pharma Inc:
* ALBIREO ENROLLS FIRST PATIENT IN PHASE 3 PFIC TRIAL OF A4250 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.